<DOC>
	<DOC>NCT03100058</DOC>
	<brief_summary>This is a dose-finding study to evaluate the change in weight after 24 weeks treatment with 8 different doses of LIK066 compared to placebo in obese or overweight adults, followed by 24 weeks treatment with 2 doses of LIK066 and placebo.</brief_summary>
	<brief_title>A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<criteria>1. informed consent 2. (BMI&gt;=30) or (BMI&gt;=27 with history of CV disease, hypertension, dyslipidemia, prediabetes or type 2 diabetes mellitus, sleepapnea syndrome) 3. willing to comply with lifestyle intervention and treatment during the full duration of the study (approximately 54 weeks) Hypersensitivity to any of the study medications Pregnancy or lactating women History of malignancies Use of pharmacologically active weight loss products Bariatric surgery Ketoacidosis, lactic acidosis, hyperosmolar coma in the 6 months before the screening visit. HbA1c &gt;10% at the screening visit.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
</DOC>